PHARMACEUTICAL COMPOSITIONS CONTAINING PSILOCYBIN FOR IMPROVED DISSOLUTION AND RAPID ONSET BY TARGETED STOMACH AND MUCOSAL RELEASE

Phamiaceutical compositions are provided containing psilocybin, which are designed for rapid dissolution properties and immediate or rapid release. The compositions are designed for targeted release by way of: (1) stomach release; or (2) mucosal release. The compositions can be used as pre-formulati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WONG, NICHOLAS JO LIE, CID, MARIA VANESA FERNANDEZ
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WONG, NICHOLAS JO LIE
CID, MARIA VANESA FERNANDEZ
description Phamiaceutical compositions are provided containing psilocybin, which are designed for rapid dissolution properties and immediate or rapid release. The compositions are designed for targeted release by way of: (1) stomach release; or (2) mucosal release. The compositions can be used as pre-formulations for further tableting, encapsulation, or formulating into a sublingual dosage form for oral use, designed for rapid therapeutic onset. Particularly, the compositions overcome unfavourable fommlati on characteristics of psilocybin that cause drug release variability and problems for formulating into finished dosage forms. More particularly, psilocybin is fommlated in a manner to overcome drug release variability thereby providing unifomi potency and desirable bioavailability characteristics. The compositions may be used for inducing therapeutically beneficial behaviour change in subjects with a variety of psychiatric conditions.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3209090A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3209090A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3209090A13</originalsourceid><addsrcrecordid>eNqNjUEKwjAQRbtxIeod5gKC2pXLMUnbgTQTkqnQVSkSV6KFegJPbhQPIH_x-fA-b1m8fIOhRWU6IYUWFLeeIwmxi3k4QXLkavCRLKv-RA4qDkCtD3w2GjTFyLb78IBOQ0BPGvLZCJx6EAy1kcxF4WxpvkzbKY7ZFYw1GM26WFzH25w2v14VUBlRzTZNjyHN03hJ9_QcFJaH3TEH9-UfyBvTmzyl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITIONS CONTAINING PSILOCYBIN FOR IMPROVED DISSOLUTION AND RAPID ONSET BY TARGETED STOMACH AND MUCOSAL RELEASE</title><source>esp@cenet</source><creator>WONG, NICHOLAS JO LIE ; CID, MARIA VANESA FERNANDEZ</creator><creatorcontrib>WONG, NICHOLAS JO LIE ; CID, MARIA VANESA FERNANDEZ</creatorcontrib><description>Phamiaceutical compositions are provided containing psilocybin, which are designed for rapid dissolution properties and immediate or rapid release. The compositions are designed for targeted release by way of: (1) stomach release; or (2) mucosal release. The compositions can be used as pre-formulations for further tableting, encapsulation, or formulating into a sublingual dosage form for oral use, designed for rapid therapeutic onset. Particularly, the compositions overcome unfavourable fommlati on characteristics of psilocybin that cause drug release variability and problems for formulating into finished dosage forms. More particularly, psilocybin is fommlated in a manner to overcome drug release variability thereby providing unifomi potency and desirable bioavailability characteristics. The compositions may be used for inducing therapeutically beneficial behaviour change in subjects with a variety of psychiatric conditions.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240215&amp;DB=EPODOC&amp;CC=CA&amp;NR=3209090A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240215&amp;DB=EPODOC&amp;CC=CA&amp;NR=3209090A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WONG, NICHOLAS JO LIE</creatorcontrib><creatorcontrib>CID, MARIA VANESA FERNANDEZ</creatorcontrib><title>PHARMACEUTICAL COMPOSITIONS CONTAINING PSILOCYBIN FOR IMPROVED DISSOLUTION AND RAPID ONSET BY TARGETED STOMACH AND MUCOSAL RELEASE</title><description>Phamiaceutical compositions are provided containing psilocybin, which are designed for rapid dissolution properties and immediate or rapid release. The compositions are designed for targeted release by way of: (1) stomach release; or (2) mucosal release. The compositions can be used as pre-formulations for further tableting, encapsulation, or formulating into a sublingual dosage form for oral use, designed for rapid therapeutic onset. Particularly, the compositions overcome unfavourable fommlati on characteristics of psilocybin that cause drug release variability and problems for formulating into finished dosage forms. More particularly, psilocybin is fommlated in a manner to overcome drug release variability thereby providing unifomi potency and desirable bioavailability characteristics. The compositions may be used for inducing therapeutically beneficial behaviour change in subjects with a variety of psychiatric conditions.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjUEKwjAQRbtxIeod5gKC2pXLMUnbgTQTkqnQVSkSV6KFegJPbhQPIH_x-fA-b1m8fIOhRWU6IYUWFLeeIwmxi3k4QXLkavCRLKv-RA4qDkCtD3w2GjTFyLb78IBOQ0BPGvLZCJx6EAy1kcxF4WxpvkzbKY7ZFYw1GM26WFzH25w2v14VUBlRzTZNjyHN03hJ9_QcFJaH3TEH9-UfyBvTmzyl</recordid><startdate>20240215</startdate><enddate>20240215</enddate><creator>WONG, NICHOLAS JO LIE</creator><creator>CID, MARIA VANESA FERNANDEZ</creator><scope>EVB</scope></search><sort><creationdate>20240215</creationdate><title>PHARMACEUTICAL COMPOSITIONS CONTAINING PSILOCYBIN FOR IMPROVED DISSOLUTION AND RAPID ONSET BY TARGETED STOMACH AND MUCOSAL RELEASE</title><author>WONG, NICHOLAS JO LIE ; CID, MARIA VANESA FERNANDEZ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3209090A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>WONG, NICHOLAS JO LIE</creatorcontrib><creatorcontrib>CID, MARIA VANESA FERNANDEZ</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WONG, NICHOLAS JO LIE</au><au>CID, MARIA VANESA FERNANDEZ</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITIONS CONTAINING PSILOCYBIN FOR IMPROVED DISSOLUTION AND RAPID ONSET BY TARGETED STOMACH AND MUCOSAL RELEASE</title><date>2024-02-15</date><risdate>2024</risdate><abstract>Phamiaceutical compositions are provided containing psilocybin, which are designed for rapid dissolution properties and immediate or rapid release. The compositions are designed for targeted release by way of: (1) stomach release; or (2) mucosal release. The compositions can be used as pre-formulations for further tableting, encapsulation, or formulating into a sublingual dosage form for oral use, designed for rapid therapeutic onset. Particularly, the compositions overcome unfavourable fommlati on characteristics of psilocybin that cause drug release variability and problems for formulating into finished dosage forms. More particularly, psilocybin is fommlated in a manner to overcome drug release variability thereby providing unifomi potency and desirable bioavailability characteristics. The compositions may be used for inducing therapeutically beneficial behaviour change in subjects with a variety of psychiatric conditions.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3209090A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PHARMACEUTICAL COMPOSITIONS CONTAINING PSILOCYBIN FOR IMPROVED DISSOLUTION AND RAPID ONSET BY TARGETED STOMACH AND MUCOSAL RELEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T14%3A22%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WONG,%20NICHOLAS%20JO%20LIE&rft.date=2024-02-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3209090A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true